A.M. Ortiz et al. / Journal of Organometallic Chemistry 694 (2009) 2037–2042
2041
3.1. X-ray crystallography
3.1.4. Diphenyl[2-(4-hydroxypiperidin-1-yl)methylferrocen-1-yl]
stibine (5)
The X-ray intensity data were measured at 293 K on a Bruker
SMART APEX CCD-based X-ray diffractometer using a monochro-
4-Hydroxypiperidine was used for the reaction. Yellow Solid
(20%); Empirical formula: C28H30FeNOSb; m.p: 126 °C (dec.); IR
matized Mo K
a
radiation (K
a
0.71073 Å). The detector was placed
(m
cmꢃ1): 3476 (O–H), 3057 (C–H aromatic), 1428 (O–H), 1063
at a distance of 4.837 cm from the crystals in all cases. Analysis of
the data showed in all cases negligible decays during data collec-
tions. An analytical face indexed absorption correction was ap-
plied. Crystal structures were refined by full-matrix least squares.
SMART software (data collection and data reduction) and SHELXTL
were used for solution and refinement of the structures.
(C–O), 452 (Sb–C) FAB+ m/z 573 (58%) [M]+, 440 (50%)
[Mꢃ56]+, 397 (100%) [FcCH2SbPh]+, 275 (13%) [SbPh2]+; 1H
NMR (CDCl3, d ppm) 1.20 (m, 4H, -CH2CH2), 1.40 (m, 1H, OH),
1.83–1.99 (m, 2H, CH2), 2.43–2.63 (m, 2H, CH2), 3.01 (d2 JHH
,
12.9 Hz, 1H, CH2N), 3.79 (d2 1H JHH, 12.9 Hz,, CH2N), 3.79 (m,
1H, C5H3), 3.39 (m, 1H, CH), 4.0 (s, 5H, C5H5), 4.20 (t, 1H,
C5H3), 4.30 (m, 1H, C5H3), 7.25–7.31 (m, 5H, Ph), 7.45–7.56 (m,
5H, Ph); 13C NMR (CDCl3, ppm) 33.2 (Cm), 34.0 (Cm ), 49.6 (Cl),
0
3.1.1. Diphenyl[2-(furan-2-ylmethylamino)methylferrocen-1-
yl]stibine (2)
0
51.1 (Cl ), 58.7 (Cg), 67.8 (Cp), 69.1 (Ca), 69.5 (Cf), 72.3 (Cd),
0
0
72.3 (Cb), 74.1 (Ce), 90.5 (Cc), 128.0, 128.3 (Cj, Cj ,Ck, Ck ), 135.7,
The compound was synthesized by a similar procedure to gen-
eral synthesis and furfuryl amine was used for the reaction. The
single crystals of the compound were grown in pentane. Yield;
0
0
136.6 (Ci, Ci ) 138.6, 140.4(Ch, Ch ).
m.p.: 86–88 °C; IR (
m
cm–1): 454 (Sb–C), 2922, 2852 (C–H ali-
3.1.5. Diphenyl[2-(4-ethylpiperazin-1-yl)methylferrocen-1-yl]stibine
phatic), 3060 (C–H aromatic), 3386 (N–H hydrogen-bonded);
FAB+ m/z: 569 (75%) [M]+, 473 (100%) [M–(C4H3O)CH2NH]+, 397
(36%) [MꢃPh]+, 275 (23%) [SbPh2]+, 199 (59%) [FcCH2]+; 1H NMR
(CDCl3, d in ppm): 2.17 (br, s, 1H, NH), 3.36 (d, 1H, JHH = 13.21 Hz,
CH2), 3.45 (d, 1H, JHH = 14.58 Hz, CH2), 3.56 (d, 1H, JHH = 12.38 Hz,
CH2), 3.62 (d, 1H, JHH = 13.21 Hz, CH2), 3.72 (m, 1H, CH, C5H3),
4.07 (s, 5H, CH, C5H5), 4.23 (t, 1H, JHH = 2.20 Hz, CH, C5H3), 4.42
(m, 1H, CH, C5H3), 6.03 (d, 1H, Jln = 0.83 Hz, CH, Furan), 6.27 (m,
1H, Jlm = 1.93 Hz, CH, Furan), 7.25–7.57 (m, 11H, Ph and Furan);
13C NMR (CDCl3, d in ppm): 43.45 (Cg), 47.48 (Cp), 69.13 (Ca),
69.39 (Ce), 71.56 (Cf), 70.40 (Cb), 74.72 (Cd), 107.29 (Cc), 110.22
(6)
1-Ethylpiperazine was used for the reaction. Yellow Solid (44%);
Empirical formula: C28H30FeNOSb; m.p: 140 °C (dec.); IR (m
cmꢃ1):
3058 (C–H aromatic), 455 (Sb–C); FAB+ m/z 586 (98%) [M]+, 473
(16%) [FcCH2SbPh2]+, 397 (100%) [FcCH2SbPh]+, 275 (27%) [SbPh2]+;
1H NMR (CDCl3, d ppm) 0.91 (t, 3H, CH3), 2.21 (q, 2H, CH2), 2.26 (m,
8H, C4H8N2), 3.01 (d2 JHH, 12.9 Hz, 1H, CH2), 3.82 (d2 JHH, 12.6 Hz,
1H, CH2), 3.78 (m, 1H, C5H3), 4.0 (s, 5H, C5H5), 4.20 (t, 1H, C5H3),
4.31 (m, 1H, C5H3), 7.25–7.32 (m, 5H, Ph), 7.44–7.56 (m, 5H, Ph)
13C NMR (CDCl3, ppm) 11.6 (Cp), 51.7 (Co), 52.0 (Cl), 58.8 (Cg),
69.1 (Ca), 69.4 (Cf), 72.2 (Cd), 72.3 (Cb), 74.1 (Ce), 90.2 (Cc), 127.9,
00
0
0
0
0
(Cl), 109.70 (Cm), 110.61 (Cn) 128.29, 128.40 (Ci, Cj ) 128.55,
128.2 (Cj, Cj ,Ck, Ck ), 135.8, 136.5 (Ci, Ci ), 139.2, 140.4 (Ch, Ch ).
0
0
0
128.71 (Ck, Ck ) 135.91, 136.59 (Ci , Cj) 139.55 141.86 (Ch, Ch ).
3.1.6. Diphenyl {2-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]
methylferrocen-1-yl}stibine (7)
4-(4-Bromophenyl)-4-hydroxypiperidine was used for the reac-
tion. Yellow solid (31%); Empirical formula: C34H33BrFeNSb; m.p:
3.1.2. Diphenyl[2-(4-Acetylaniline)methylferrocen-1-yl] stibine (3)
The compound was synthesized by a similar procedure to gen-
eral synthesis p-amino acetaphenone was used for the reaction.
The compound was crystallized in hexane. Yellow Solid (42%);
145 °C (dec.); IR (
m
cmꢃ1): a 3455 cmꢃ1 (O–H), 3043 (C–H aro-
Empirical formula: C31H28FeNOSb; m.p: 147–150 °C; IR(
m
cmꢃ1):
matic), 454 (Sb–C) FAB+ m/z 728 (100%) [M]+, 650 (16%) [MꢃBr],
473 (19%) [FcCH2SbPh2]+, 397 (100%) [FcCH2SbPh]+, 275 (34%)
[SbPh2]+; 1H NMR (CDCl3, d ppm) 1.2– 2.8 (m, 8H, C5H8N), 3.01
(m, 1H, CH2), 3.80 (m, 1H, C5H3), 3.91 (d2, 1H, JHH = 12.9 Hz, CH2),
4.03 (s, 5H, C5H5), 4.21 (m, 1H, C5H3), 4.34 (m, 1H, C5H3), 6.92 (d,
2H, H–Ar), 7.56–7.31 (m, 12H); 13C NMR (CDCl3, ppm) 36.8, 38.8
3404 (N–H), 3057 (C–H aromatic), 1595(C–O), 453 (Sb–C). FAB+
m/z 607(8%) [M]+, 592 (7%) [M–CH3]+, 473 (70%) [FcCH2SbPh2]+,
397 (27%) [FcCH2SbPh]+, 275 (13%) [SbPh2]+; 1HNMR (CDCl3, d
ppm) 2.47 (s, 3H, CH3), 3.82 (m, 1H, C5H3), 3.94 (N–H), 4.01 (d2,
1H, JHH = 4.95 Hz, CH2), 4.09 (d2, 1H, JHH = 4.95 Hz, CH2), 4.15 (s,
5H, C5H5), 4.29 (t, 1H, C5H3), 4.45 (m, 1H, C5H3), 6.22 (d, 2H, H–
Ar), 6.20–6.40 (m, 10H, Ph), 7.76 (d, 2H, H–Ar); 13C NMR (CDCl3,
ppm) 25.9 (Cq), 43.6 (Cg), 69.2 (Ca), 70.5 (C, Ce), 71.9 (C, Cf), 72.16
0
0
(Cm, Cm ), 46.8,50.3 (Cl, Cl ), 58.9 (Cg), 69.1 (Ca), 70.9 (Ce), 71.0
0
0
(Cb), 72.3 (Cf), 74.2 (Cd), 120.9 (Ct), 126.4 (Cr, Cr ), 130.9 (Cs, Cs ),
0
0
0
128.0, 128.5 (Cj, Cj ,Ck, Ck ), 135.5, 136.5 (Ci, Ci ).
0
(Cb), 74.6 (Cd), 90.0 (Cc), 111.4 (Cn, Cn ), 126.9 (Co), 128.5, 128.9
0
0
0
0
(Cj, Cj , Ck, Ck ), 130.5 (Cm, Cm ), 135.9, 136.4 (Ch, Ch ), 136.6, 139.0
Acknowledgements
0
(Cj, Cj ), 151.2 (Cl), 196.2 (Cp).
Authors are thankful to DGAPA(IN206809) for financing the
work. We are also thankful to Javier Perez Flores for their assis-
tance in mass spectral studies.
3.1.3. Diphenyl {2-[3-(1-hydroxyethyl)aniline]methylferrocen-1-
yl}stibine (4)
3-(1-Hydroxyethyl)-aniline was used in place of p-aminoaceta-
phenone. Yellow Solid (35%); Empirical formula: C31H28FeNOSb;
m.p: 86–88 °C; IR (m
cmꢃ1): 3384 (O–H) y (N–H), 3057 (C–H aro-
matic), 455 (Sb–C) FAB+ m/z 609 (100%) [M]+, 532 (5%) [MꢃPh]+,
473 (38%) [FcCH2SbPh2]+, 397 (15%) [FcCH2SbPh]+, 275 (15%)
[SbPh2]+; 1H NMR (CDCl3, d ppm) 1.44 (d, 3H, CH3), 1.53 (s, 1H,
NH), 3.77 (m, 1H, C5H3), 3.94 (d, 1H, CH2), 3.86 (s, 5H, C5H5), 4.27
(m, 1H, C5H3), 4.46 (m, 1H, C5H3), 4.06 (m, 1H, CH2), 4.74 (m, 1H,
CH), 6.31 (m, 2H, H–Ar), 6.66 (m, 1H, H–Ar), 7.07 (m, 1H, H–Ar),
7.25–7.38 (m, 10H, Ph); 13C NMR (CDCl3, ppm) 24.8 (Cq), 44.2
(Cg), 69.1 (Ca), 70.3 (Ce), 71.2 (Cp), 72.5 (Cd), 74.6 (Cf), 109.7 (Cm),
Appendix A. Supplementary material
CCDC 698470, 698471, 698472 and 698473 contain the sup-
plementary crystallographic data for compound (2), (3), (5) and
(7). These data can be obtained free of charge from The Cam-
can be found, in the online version, at doi:10.1016/
j.jorganchem.2008.07.019.
0
00
0
0
0
112.0 (Cn), 128.4, 129.8 (Cn , Cn , Ck, Ck , Cj, Cj ), 135.7,136.7 (Ci, Ci ).